Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer

This study has been completed.
Quintiles, Inc.
Information provided by:
Taiho Oncology, Inc. Identifier:
First received: March 31, 2008
Last updated: March 17, 2011
Last verified: March 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2007
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)